The blood–brain barrier permeable small molecule inhibitor of IGF-1-R, picropodophyllin (PPP) [96], shows promising antitumoral effects in treatment of gliomas [97] and could be used for another way of disrupting paracrine neuron-tumor signaling. Here, IGF1R is linked to neoplasm.